A diverse group of drugs that counteract the effects of dihydrotestosterone, testosterone, and the male sex hormones are called antiandrogens. They are also known as testosterone blockers, androgen receptor blockers, and androgen antagonists. Some antiandrogens limit the body’s ability to make use of androgens by blocking androgen receptors. Other antiandrogens reduce the body’s ability to produce androgens. Antiandrogens are used for the treatment of various disorders and conditions, including sexual disorders such as hypersexuality, male pattern hair loss (androgenic alopecia), benign prostatic hyperplasia, precocious puberty in young males, and prostate cancer in men. In women, antiandrogens are used for the treatment of acne, amenorrhea (absence of menstrual periods), hirsutism (excessive facial or body hair), polycystic ovarian syndrome, and many other indications.

Uncontrolled growth of abnormal cells in the prostate gland can cause prostate cancer. This condition is not always dangerous, but it is common. The reason is that the gland grows very slowly. Prostate cancer occurs in older men, and the average age of diagnosis is 70 years. The condition can be normally diagnosed before it causes any symptoms. Men at this age also suffer from other illnesses that need more attention than the cancer that does not produce visible symptoms. The malignant cancerous cells of the prostate clump together and form small cancerous tumors. In most cases, it takes many years, even a few decades, for the localized cancer to spread beyond the prostate. And many of antiandrogens cancers never spread.

Alopecia involves loss of hair or balding. The condition is not restricted to the head and can cause loss of hair on any part of the body. Some types of alopecia cause permanent loss of hair, and in other cases the hair loss is temporary. Testosterone is a dominant sex hormone in men that falls in the broad category of hormones called androgens. About 4% to 7% women produce too much testosterone in the ovaries. Antiandrogens women suffer from a condition known as polycystic ovarian syndrome. The condition can cause excessive hair growth in certain areas of a woman's body such as the chin and above the lips. It can also cause acne and amenorrhea. Acne is a common skin condition. It is caused by inflammation of the oil-producing (sebaceous) glands and hair follicles of the skin. Amenorrhea is the absence of menstruation in women of child bearing age.

Increase in prevalence of hypersexuality, androgenic alopecia (male pattern hair loss), benign prostatic hyperplasia, precocious puberty in young males, and prostate cancer in men is likely to drive the antiandrogens market during the forecast period. Moreover, rise in acne, amenorrhea (absence of menstrual periods), hirsutism (excessive facial or body hair), polycystic ovarian syndrome in women is expected to propel the antiandrogens market. According to Sexual Health Matters, there are approximately 5.7 million adults in the U.S. who live with hypersexuality disorder. According to the American Hair Loss Association, every year androgenic alopecia or common male pattern baldness accounts for approximately more than 95% of hair loss in men in the U.S.

The global antiandrogens market can be segmented based on gender, indication, distribution channel, and region. In terms of gender, the antiandrogens market can be classified into males and females. Based on indication, the antiandrogens market can be categorized into prostate cancer, precocious puberty in young males, benign prostatic hyperplasia, androgenic alopecia, hypersexuality, polycystic ovarian syndrome, hirsutism, amenorrhea, and acne. In terms of distribution channel, the antiandrogens market can be divided into retail pharmacies, online pharmacies, and hospital pharmacies.

In terms of region, the antiandrogens market can be categorized into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. North America held a dominant antiandrogens market share in 2016 due to rise in prevalence of benign prostatic hyperplasia in the region. Europe held a significant antiandrogens market share in 2016 owing to rise in prevalence of hirsutism. According to the U.S. National Library of Medicine, National Institutes of Health, hirsutism is present in 40% to 92% females in Europe and North America. The antiandrogens market in Asia Pacific is anticipated to expand during the forecast period. The antiandrogens market in Middle East & Africa and Latin America is expected to expand during the forecast period owing to increase in prevalence of prostate cancer, precocious puberty in young males, benign prostatic hyperplasia, androgenic alopecia, hypersexuality, polycystic ovarian syndrome, hirsutism, amenorrhea, and acne.

Key players in the global antiandrogens market include Teva Pharmaceutical Industries Ltd., Astellas Pharma US, Inc., ANI Pharmaceuticals, Inc., and AstraZeneca.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Antiandrogens Market

Pre Book